From L.A. Times Studios: Four questions and answers about the California variant

A new strain of the coronavirus recently surfaced in Southern California, concerning public health officials as it spreads worldwide. Los Angeles Times executive chairman Dr. Patrick Soon-Shiong answers four key questions about the California variant.

Patrick Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious disease. Last year, Soon-Shiong’s company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate. He has also received approval to begin trials in South Africa, where he will explore the potential of his T cell vaccine to prevent infection from mutated virus strains of the coronavirus.